May 21, 2020 -- Open Philanthropy has advanced $7.5 million in grant funding to engineering biology company Sherlock Biosciences for diagnostics related to the novel coronavirus.
The nondilutive grant funding will help Sherlock further advance its CRISPR gene-editing technology platform, which it used to create its Sherlock CRISPR SARS-CoV-2 detection kit. The funding will also support the development of the company's Inspectr platform, which powers its COVID-19 diagnostic.
Sherlock is currently looking to hire 10 to 15 molecular diagnostic experts to help advance its Inspectr-based COVID-19 solution. The Inspectr platform aims to conduct instrument-free, handheld diagnostic tests that work similarly to an at-home pregnancy test.
When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.Yes, Keep Me Current